Latest Structure Therapeutics News & Updates

See the latest news and media coverage for Structure. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Structure Therapeutics (Structure)

Clinical-stage biopharmaceutical company developing oral small molecule therapeutics

structuretx.com
Headquarters
South San Francisco, United States
Founded year
2017
Company type
Public company
Number of employees
50–250
Industry
Pharmaceuticals

Last updated

Latest news about Structure Therapeutics (Structure)

In short: Structure Therapeutics announced successful Phase 2 trial results for its oral obesity drug aleniglipron, showing up to 16.3% weight loss.

Company announcements

Structure

Structure Therapeutics appoints Matthew Lang as COO and General Counsel

Lang brings over 15 years of biopharma experience in legal, strategy, and operations. He previously served at Metsera, Lyell Immunopharma, and Myovant.

Unlock all announcements with a

Media coverage

BioSpace

ADA: AstraZeneca hands Structure a win with ‘relatively underwhelming’ GLP-1 pill data - BioSpace

AstraZeneca’s GLP-1 pill ... outperform a key competitor from Structure Therapeutics. The pharma’s asset, dubbed elecoglipron, showed “promising efficacy” in the Phase 2b VISTA study...

Unlock all articles with a

Never miss news about Structure

Track Structure and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Structure competitors & trending companies

Browse news for competitors to Structure and other trending companies.